OpenVSafe by OpenVAERS
Search V-safe

FA9-30584-34801

1 vaccination 4 coded responses 15 check-ins 4 free-text entries 0 call cases
Sex
Female
Age at first dose
66+
ZIP prefix
921 / CA
Registered
2021-02-03
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-02-03
    Registered in v-safe
  2. 2021-02-03
    Dose 1 — Moderna
  3. 2021-02-03
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-02-04
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-02-05
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2021-02-06
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Redness, Itching · Rash, not including the immediate area around the injection site
    Adult check-in
  7. 2021-02-07
    Survey response — days 1–6 daily, dose 1
    MedDRA: Injection site reaction, Rash erythematous — Feeling: Good · Rash, not including the immediate area around the injection site
    Free text: Red rash on arm below injection site in form of a circle.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-02-08
    Survey response — days 1–6 daily, dose 1
    MedDRA: Injection site erythema — Feeling: Good · Rash, not including the immediate area around the injection site
    Free text: Redness on arm below vaccine site. Circular.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-02-09
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Rash, not including the immediate area around the injection site
    Adult check-in
  10. 2021-02-10
    Health check-in — day 7, dose 1
    Feeling: Good · Rash, not including the immediate area around the injection site
    Adult check-in
  11. 2021-02-17
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-02-24
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  13. 2021-03-03
    Health check-in — day 28, dose 1
    Feeling: Good
    Adult check-in
  14. 2021-03-10
    Health check-in — day 35, dose 1
    Feeling: Good
    Adult check-in
  15. 2021-05-05
    Survey response — 3 months, dose 1
    MedDRA: Fatigue, Injection site erythema, Injection site induration, Injection site pain, Injection site pruritus — Feeling: Good
    Free text: After second injection, I had a sore , red ,hard arm at injection site. After 2-3 days the hardness went away and arm began to itch. Was very fatigued for 2 days and slept a lot. After 5 days was normal. Second dose was delayed 2 weeks. Short supply.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-08-04
    Health check-in — 6 months, dose 1
    Feeling: Good
    Adult check-in
  17. 2022-02-03
    Survey response — 12 months, dose 1
    MedDRA: Nasopharyngitis, SARS-CoV-2 test negative — Feeling: Good
    Free text: Mild cold. Tested negative for Covid-19 on PCR test. Lasted about a week.
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-02-03Moderna

Free text

Release 3 — days 1–6 daily, dose 1

2021-02-07

Systemic reaction (other): Red rash on arm below injection site in form of a circle.

2021-02-08

Systemic reaction (other): Redness on arm below vaccine site. Circular.

Release 8 — 3 months, dose 1

2021-05-05

Symptoms: After second injection, I had a sore , red ,hard arm at injection site. After 2-3 days the hardness went away and arm began to itch. Was very fatigued for 2 days and slept a lot. After 5 days was normal. Second dose was delayed 2 weeks. Short supply. cut off by CDC

Release 11 — 12 months, dose 1

2022-02-03

Symptoms: Mild cold. Tested negative for Covid-19 on PCR test. Lasted about a week.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDFatigue ✓ ✓ ✓
SDInjection site erythema ✓ ✓ ✓
SDInjection site induration ✓ ✓ ✓
SDInjection site pain ✓ ✓ ✓
SDInjection site pruritus ✓ ✓ ✓
SDNasopharyngitis · · ✓
SDSARS-CoV-2 test negative · · ✓
SROInjection site erythema ✓ ✓ ✓
SROInjection site reaction ✓ ✓ ✓
SRORash erythematous ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release